Do immune cells promote the pathology of dystrophin-deficient myopathies?
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 11 (6-7) , 556-564
- https://doi.org/10.1016/s0960-8966(01)00198-5
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Helper (CD4+) and Cytotoxic (CD8+) T Cells Promote the Pathology of Dystrophin-Deficient MuscleClinical Immunology, 2001
- Complement Activation Promotes Muscle Inflammation during Modified Muscle UseThe American Journal of Pathology, 2000
- Eosinophilia of Dystrophin-Deficient Muscle Is Promoted by Perforin-Mediated Cytotoxicity by T Cell EffectorsThe American Journal of Pathology, 2000
- Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity.Journal of Clinical Investigation, 1997
- Identification of Cardiac Autoantigens in Human Heart CDNA Libraries Using Acute Rheumatic Fever SeraJournal of Autoimmunity, 1994
- The pathological damage in duchenne muscular dystrophy may be due to increased intracellular oxy-radical generation caused by the absence of dystrophin and subsequent alterations in Ca2+ metabolismMedical Hypotheses, 1989
- INCREASED EXPRESSION OF HLA ABC CLASS I ANTIGENS BY MUSCLE FIBRES IN DUCHENNE MUSCULAR DYSTROPHY, INFLAMMATORY MYOPATHY, AND OTHER NEUROMUSCULAR DISORDERSThe Lancet, 1985
- Immunohistochemical characterization of the mononuclear cells infiltrating muscle of patients with inflammatory and noninflammatory myopathiesClinical Immunology and Immunopathology, 1984
- Experimental myositis: The in-vivo and in-vitro activity of lymph-node cellsThe Journal of Pathology, 1971
- In vitro Destruction of Skeletal Muscle By Sensitized CellsNature, 1966